Silk Road Medical Inc. announced that Chas McKhann has been appointed Chief Executive Officer, effective immediately. Mr. McKhann is an accomplished leader with more than 25 years of experience in the medical device industry, including C-suite positions at seven public and private companies. Most recently, Mr. McKhann served as President and CEO of Apollo Endosurgery, where he created and led a transformational growth strategy for the company?s minimally invasive technologies for gastrointestinal and bariatric conditions.

Previously, he held leadership positions at Torax Medical and Intersect ENT, among others. Mr. McKhann succeeds Erica Rogers, who has now retired from the President and CEO role and will continue as an advisor to the Company?s Board of Directors. Before joining Silk Road, Mr. McKhann was President and CEO of Apollo Endosurgery where he created and led a transformational growth strategy for the company?s minimally invasive technologies for gastrointestinal and bariatric conditions.

He led the company through multiple product approvals through the FDA De Novo pathway and oversaw the company?s successful sale to Boston Scientific, which closed in April 2023. Prior to Apollo, Mr. McKhann was Chief Commercial Officer at Rox Medical, where he developed a global commercial strategy for a novel therapy for hypertension and supported clinical trial enrollment in advance of regulatory clearance. Mr. McKhann was previously Chief Commercial Officer at Torax Medical, acquired by Johnson & Johnson in 2017, and Intersect ENT, which was later acquired by Medtronic in 2022.

Previously, Mr. McKhann was CEO at Apnex Medical, a developer of a hypoglossal nerve stimulator for obstructive sleep apnea, global head of marketing of cardiac rhythm management at Boston Scientific, and Director of Marketing at Cordis, a unit of Johnson & Johnson, where he was the marketing lead for CYPHER®, a sirolimus-eluting coronary stent that was the first cardiac drug-eluting stent. Mr. McKhann began his career as a strategy consultant at SCA Consulting and McKinsey & Company. He holds a BA in Political Science and an MBA from Stanford University.